Why Is Eli Lilly (LLY) Being Sued Over Alleged Insulin Price Inflation?

Eli Lilly (NYSE:LLY) faces a new Pennsylvania lawsuit alleging drugmakers inflated insulin prices by over 1,000%. The complaint, filed on behalf of state consumers, targets Eli Lilly and other large insulin manufacturers and pharmacy benefit managers. Plaintiffs argue the alleged pricing scheme significantly increased out of pocket insulin costs for patients in Pennsylvania. This alleged 1,000% insulin price inflation is only one piece of the wider Eli Lilly story investors are assessing...